Thanks Phil, Honestly was a nobrainer. Anything Ebola,The

New Post Public Reply Private Reply Replies (0) Message Board
fitzkarz MicroCapStocksRock #1005
Thanks Phil, Honestly was a nobrainer.
Anything Ebola,The new fad!

Posted On: 10/16/2014 8:41:46 AM
Avatar
Posted By: fitzkarz
$IBIO please read!
iBio Responds to Inquiries About its Role in Emergency Response to Ebola Virus Disease Outbreak

NEWARK, DE--(Marketwired - Oct 16, 2014) - iBio, Inc. (NYSE MKT: IBIO) today confirmed, in response to shareholder and media inquiries: (i) the applicability of its issued U.S. iBioLaunch™ platform patents and related proprietary technology to further development and production of antibodies that target the Ebola virus, and (ii) that iBio has an ongoing relationship with Caliber Biotherapeutics LLC reflected by a License and Collaboration Agreement dated February 14, 2013 pursuant to which iBio and Caliber have been collaborating on commercial opportunities for recombinant antibodies and antibody-related proteins based on the speed, efficiency, and cost advantages of producing pharmaceutical proteins in plants instead of with bioreactor-based manufacturing methods.

Based on published scientific data, the superior homogeneity of antibody glysolylation (the addition of sugars to proteins) in plants can provide significant efficacy advantages over similar antibodies produced in Chinese hamster ovary (CHO) cells.

iBio has offered to assist the U.S. government by making its proprietary technology available for emergency use to enable the manufacture and yield optimization of certain experimental antibody-based drugs that address the current Ebola virus outbreak, to the extent such assistance is requested by the government.

About iBio, Inc.

iBio owns the iBioLaunch™ platform, which is a proprietary, transformative technology for development and production of biologics using transient gene expression in unmodified green plants. iBio is developing a proprietary product for the treatment of idiopathic pulmonary fibrosis, systemic sclerosis, and other fibrotic diseases using its iBioLaunch platform. The company also offers technology licenses to others and provides collaborators full support for turn-key implementation of its technology for protein therapeutics, such as antibodies, and vaccines. In Brazil, iBio has been collaborating with Oswaldo Cruz Foundation (Fiocruz) since 2011 to develop a recombinant yellow fever vaccine based upon iBio technology. Further information is available at: www.ibioinc.com.

FORWARD-LOOKING STATEMENTS

STATEMENTS INCLUDED IN THIS NEWS RELEASE RELATED TO IBIO, INC. MAY CONSTITUTE FORWARD-LOOKING STATEMENTS WITHIN THE MEANING OF THE PRIVATE SECURITIES LITIGATION REFORM ACT OF 1995. SUCH STATEMENTS INVOLVE A NUMBER OF RISKS AND UNCERTAINTIES SUCH AS COMPETITIVE FACTORS, TECHNOLOGICAL DEVELOPMENT, MARKET DEMAND, AND THE COMPANY'S ABILITY TO OBTAIN NEW CONTRACTS AND ACCURATELY ESTIMATE NET REVENUES DUE TO VARIABILITY IN SIZE, SCOPE AND DURATION OF PROJECTS. FURTHER INFORMATION ON POTENTIAL RISK FACTORS THAT COULD AFFECT THE COMPANY'S FINANCIAL RESULTS CAN BE FOUND IN THE COMPANY'S REPORTS FILED WITH THE SECURITIES AND EXCHANGE COMMISSION.

Investor Relations Contact
Ron Both
Liolios Group, Inc.
Tel 949-574-3860
Email Contact

Source: Marketwired (October 16, 2014 - 8:31 AM EDT)

News by QuoteMedia
I'm in it to win it!

NASDAQ DIP and RIP
Here is the best word that describes what i do here.
Intuitive;
means having the ability to understand or know something without any direct evidence or reasoning process.

I was born with it, I'm truly blessed!


Alway's searching for winners'
937206596_images.jpg
Scroll down for more posts ▼

Top 10 Most Recent News Articles

Heineken Hit with €111M Judgment—A Precedent Set

Updated Category News Views 7

A Brew of Legal Consequences for Heineken If this isn't a financial wake-up call for the brewing giant, I don't know what is. In the latest twist of corporate accountability, the Amsterdam District Court has ordered Heineken and its Greek subsidiary, Athenian Brewery, to cough up a whopping €111 million. And we're not just talking pocket change—this ruling speaks...

Continue Reading
Doximity Lawsuit: Investors Face November Deadline

Updated Category News Views 0

Hard Knocks for Doximity Investors Alright, so this isn't the place I usually find myself at that hour, but we're living in wild times if you're clinging to Doximity (NYSE:DOCS) shares. Listen up, because those lawyers are chiming in and they ain't just whistling Dixie. If you bought into DOCS between August 2024 and May 2026 and watched your investment bleed red ink,...

Continue Reading
Fresenius Revamps U.S. Kidney Care with multiFiltratePRO

Updated Category News Views 3

Fresenius Takes a Giant Leap in Kidney Care Fresenius Medical Care is breaking new ground in the U.S., marking a significant milestone with the introduction of the multiFiltratePRO System for critically ill patients battling acute kidney injury (AKI). This isn't some run-of-the-mill equipment upgrade. It's an evolution in how critical care teams manage continuous kidney...

Continue Reading
Cesar Alvarez Honored with Prestigious Miami Award

Updated Category News Views 0

Cesar Alvarez's Legacy Honored in Miami The Greater Miami Chamber of Commerce's 2026 Sand in My Shoes® Award has found its latest recipient in Cesar L. Alvarez, the Senior Chairman of Greenberg Traurig, P.A. It wasn't just a ceremony—this was a gathering of more than 800 of Miami's business and community power players on October 15, 2026. And man, did it shine a bright...

Continue Reading
FFR Set to Unveil Strategy at Nasdaq Event in NYC

Updated Category News Views 12

An Exciting Day for FFR on Wall Street Hold onto your hats, investors! FF EAI Robotics Ecosystem Inc. (NASDAQ: FFR) is about to make a splash in the big leagues at its much-anticipated Nasdaq listing ceremony. Slated for October 26 at the iconic Nasdaq Tower in NYC, it's a day that could pivot the company’s future centerpiece strategy, jacking up anticipation like...

Continue Reading
Red Banyan Wins Inc. Power Partner Award for 3rd Year

Updated Category News Views 9

Red Banyan: A Powerhouse in B2B Support Red Banyan isn't just any player in the communications game; it's carved out a reputation as the go-to when businesses hit rough waters. You see, for the third consecutive year, this Fort Lauderdale-based firm bagged the Inc. Power Partner Award—a nod to its clout in the B2B arena. This accolade ain't about fancy ads; it's about...

Continue Reading
Tigo Energy Faces Rough Waters Amidst Class Action

Updated Category News Views 2

Shareholders Feel the Burn with Tigo's Stock Plunge The latest twist in the Tigo Energy saga has left investors reeling. The big hitters like Glancy Prongay Wolke & Rotter LLP have stepped into the ring, shaking the trees over allegations of securities fraud that have shaken confidence in NASDAQ:TYGO. In just a day, Tigo's shares have nose-dived over 36% thanks to this...

Continue Reading
Vermilion Energy Sets Dates for Earnings and Calls

Updated Category News Views 1

The Anticipation Around Vermilion's Upcoming Results There's a buzz in the air about Vermilion Energy Inc.'s upcoming Q3 2026 financial results. Slated to hit the wires November 4th, before the sun rises on Wall Street, folks in the trade have their eyes peeled to parse through any morsels of data. The question on everyone's mind? Whether they're making the right moves to...

Continue Reading
American Lung Association Tackles Indoor Pollution

Updated Category News Views 4

The Unseen Threat Lurking Indoors When you think about air pollution, your mind probably jumps to smog-choked city streets. But, surprise! The air inside your cozy living room could actually be pulling a fast one on you, being two to five times filthier than what’s outside. Now, that’s a hair-raising thought. A Closer Look at Indoor Air Hazards Folks don’t usually...

Continue Reading
TrueLoyal Unveils Tool to Target Loyalty Campaigns Smartly

Updated Category News Views 5

Decoding New Loyalty Strategies with TrueLoyal In this cutthroat market, loyalty's the name of the game, and TrueLoyal just rolled out a sharp new tool that's got me raising an eyebrow. Their Advanced Analytics is shaking up the way brands look at their loyalty programs. This ain't your granddad's analytics tool—it promises to cut the fat and put your spending where it...

Continue Reading

Top 5 Most Recently Viewed Articles

Understanding the Growth of $100 Invested in KKR Over a Decade

Updated Category News Views 137

The Remarkable Growth of KKR Over the Past Decade Investing in KKR (NYSE: KKR) ten years ago would have been a smart move for any investor. Throughout this decade, KKR has consistently outperformed market expectations, achieving an impressive annualized return of 19.49%. This standout performance exceeds the market average by 8.29%, highlighting the potential of strategic...

Continue Reading
Therap Services Launches T-Log Module for Enhanced Communication

Updated Category News Views 233

Enhancing Communication with Therap's T-Log Module Therap Services, a prominent player in the realm of HIPAA-compliant electronic documentation solutions, is committed to empowering agencies within the Long-Term Services and Supports (LTSS), Home and Community-Based Services (HCBS), and various other human services sectors. With the introduction of its innovative T-Log...

Continue Reading
BioMarin Secures $850 Million in Senior Notes for Growth Strategy

Updated Category News Views 98

BioMarin Unveils New Funding Strategy for Expansion BioMarin Pharmaceutical Inc. (NASDAQ: BMRN) recently announced its successful pricing of a significant offering of $850 million in senior unsecured notes, due 2034. These notes carry a fixed interest rate of 5.500%, with an issue price set at 100.000%. The anticipated closing date for this offering is just around the...

Continue Reading
Piramal Pharma Limited's Financial Highlights for Q3 FY25

Updated Category News Views 388

Piramal Pharma Limited Financial Results Overview Piramal Pharma Limited (NSE: PPLPHARMA, BSE: 543635) has announced compelling results for the third quarter (Q3) and the first nine months (9M) of FY25, highlighting a strong performance in the pharmaceutical and wellness sectors. Consolidated Financial Highlights The company reported significant financial metrics, with...

Continue Reading
Five Star Development Navigates Chapter 11 for Project Completion

Updated Category News Views 368

Five Star Development Takes Steps for Project Protection Five Star Development, LLC, alongside affiliated entities, has recently announced its decision to file for Chapter 11 bankruptcy protection in the U.S. Bankruptcy Court. This pivotal move aims to ensure that the ambitious project known as The Palmeraie, which includes The Ritz-Carlton Paradise Valley, can be...

Continue Reading